Allergan

Allergan eye drug fails to impress on safety, upping pressure ahead of key meeting
Biopharma Dive
Wed, 04/3/19 - 12:22 pm
Allergan
abicipar
wet age-related macular degeneration
Does an improved safety profile strengthen Allergan's case for a wet AMD challenge to Lucentis?
Endpoints
Tue, 04/2/19 - 12:04 pm
Allergan
abicipar
wet age-related macular degeneration
Lucentis
Molecular Partners
Allergan taps Celgene vet Hugin for M&A guidance, but proxy brawlers aren't impressed
Fierce Pharma
Mon, 03/25/19 - 10:32 pm
Allergan
investors
M&A
Bob Hugin
Allergan's NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA
BioSpace
Tue, 03/19/19 - 10:29 am
Allergan
migraines
ubrogepant
FDA
Allergan Rises After FDA Accepts License Applications for Botox Supplements
TheStreet.com
Fri, 03/8/19 - 09:41 am
Allergan
Botox
FDA
pediatrics
limb spascity
Allergan investors, rooting for a breakup, cheer rapastinel's phase 3 flop
Fierce Pharma
Thu, 03/7/19 - 09:26 pm
Allergan
investors
rapastinel
‘Brutal disaster.’ Allergan’s would-be antidepressant fails patients in four studies
Stat
Wed, 03/6/19 - 08:24 pm
Allergan
antidepressants
repastinel
clinical trials
What do Allergan activists really want? A new CEO to replace Saunders, analyst says
Fierce Pharma
Tue, 03/5/19 - 12:03 pm
Allergan
activists
Pharma CEOs
Brent Saunders
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
market exclusivity
patents
Rituxan
Lyrica
Herceptin
Avastin
Epclusa
Harvoni
Pfizer
Roche
Gilead Sciences
Amgen
GSK
Allergan
Individor
Sorry, Allergan. Another activist backs an immediate split to CEO, chairman jobs
Fierce Pharma
Fri, 03/1/19 - 08:28 pm
Allergan
Brent Saunders
Pharma CEOs
Under-pressure Allergan backs a CEO-chairman job split—just not right now
Fierce Pharma
Tue, 02/19/19 - 11:28 pm
Allergan
Pharma CEOs
Brent Saunders
Evolus' Botox competitor is here. Will it dent Allergan's sales?
Fierce Pharma
Mon, 02/4/19 - 08:52 pm
Allergan
Botox
Evolus
Jeuveau
Even with new competition, Botox can hold its own in growing migraine field: Allergan executives
Fierce Pharma
Thu, 01/31/19 - 11:49 am
Allergan
Botox
Amgen
Eli Lilly
Teva Pharmaceuticals
migraines
Allergan sheds $4.5B in market cap on 4Q18 earnings
BioCentury
Tue, 01/29/19 - 11:22 pm
Allergan
earnings
Is the Smoldering NASH Market Ready to Burst Into Flames?
BioSpace
Tue, 01/22/19 - 11:52 am
NASH
Allergan
Regeneron
Alnylam
AstraZeneca
Merck
Takeda
Gilead Sciences
Bristol-Myers Squibb
Intercept Pharmaceuticals
Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy
Endpoints
Tue, 01/22/19 - 11:43 am
Aurinia Pharmaceuticals
voclosporin
eye health
dry eye disease
Allergan
Restasis
Tribe, Allergan appeal sovereign immunity patent case to Supreme Court
BioCentury
Wed, 01/16/19 - 12:04 am
Allergan
Supreme Court
inter partes review
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Mon, 01/14/19 - 11:11 am
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
Report: Pharma companies kick off new year with price hikes
Drug Delivery Business News
Wed, 01/2/19 - 10:11 am
Allergan
Bristol-Myers Squibb
Biogen
Pfizer
drug pricing
Shire gears up to battle Allergan's Linzess with new constipation drug Motegrity
Fierce Pharma
Wed, 12/19/18 - 12:25 am
Takeda
Shire
Allergan
chronic idiopathic constipation
Motegrity

Pages